DuPont: A Premier Multi-Industrial Company

DUPONT OVERVIEW

A premier multi-industrial company

May 3, 2024

Overview

On November 1, 2023, DuPont completed the divestiture of the Delrin® acetal homopolymer (H-POM) business to TJC LP, (the "Delrin® Divestiture"). The results of operations for the three months ended March 31, 2023 present the financial results of the Delrin® Divestiture as discontinued operations. Unless otherwise indicated, the discussion of results, including the financial measures further discussed below, refers only to DuPont's Continuing Operations and does not include discussion of balances or activity of the Delrin® Divestiture.

Effective as of January 1, 2024, Electronics & Industrial realigned certain product lines that comprise its business units (Industrial Solutions, Interconnect Solutions and Semiconductor Technologies) that are intended to optimize business operations across the segment leading to enhanced value for our customers and cost savings. The Net Trade Revenue by Segment and Business or Major Product Line table on slide 50 has been recast for all periods presented to reflect the new structure. The realignment did not result in changes to total Electronics and Industrial segment net sales.

FORWARD-LOOKING STATEMENTS

This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance.

Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: i) the possibility that the Company may fail to realize the anticipated benefits of the $1 billion share repurchase program announced on February 6, 2024 and that the program may be suspended, discontinued or not completed prior to its termination on June 30, 2025; (ii) risks and uncertainties related to the settlement agreement concerning PFAS liabilities reached June 2023 with plaintiff water utilities by Chemours, Corteva, EIDP and DuPont; (iii) risks and costs related to each of the parties respective performance under and the impact of the arrangement to share future eligible PFAS costs by and between DuPont, Corteva and Chemours, including the outcome of any pending or future litigation related to PFAS or PFOA, including personal injury claims and natural resource damages claims; the extent and cost of ongoing remediation obligations and potential future remediation obligations; changes in laws and regulations applicable to PFAS chemicals; (iv) ability to achieve anticipated tax treatments in connection with completed and future, if any, divestitures, mergers, acquisitions and other portfolio changes actions and impact of changes in relevant tax and other laws; (v) indemnification of certain legacy liabilities; (vi) failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with completed and future, if any, divestitures, mergers, acquisitions, and other portfolio management, productivity and infrastructure actions; (vii) risks and uncertainties, including increased costs and the ability to obtain raw materials and meet customer needs from, among other events, pandemics and responsive actions; timing and recovery from demand declines in consumer- facing markets, including in China; adverse changes in worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions; and other factors beyond the Company's control, including inflation, recession, military conflicts, natural and other disasters or weather related events, that impact the operations of the Company, its customers and/or suppliers; (viii) ability to offset increases in cost of inputs, including raw materials, energy and logistics; (ix) risks associated with demand and market conditions in the semiconductor industry and associated end markets, including from continuing or expanding trade disputes or restrictions, including on exports to China of U.S.-regulated products and technology; (x) risks, including ability to achieve, and costs associated with DuPont's sustainability strategy including the actual conduct of the company's activities and results thereof, and the development, implementation, achievement or continuation of any goal, program, policy or initiative discussed or expected; and (xi) other risks to DuPont's business and operations, including the risk of impairment; each as further discussed in DuPont's most recent annual report and subsequent current and periodic reports filed with the U.S. Securities and Exchange Commission. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

2

Table of Contents

• Our Transformation Journey
• DuPont's Business Today
• FY 2023 Financial Summary
• Growth Strategy and Drivers
• Segment Overviews

3

Our Transformation Journey

A Significant Transformation

Creating a premier multi-industrial company

Announce merger between Dow

2015 and EID

Specialty Products division of DowDuPont

A combination of world-class businesses with focus in secular growth areas:

• Electronics (EID & Dow)
• Water (Dow)
• Protection (EID & Dow)
• Industrial Technologies (EID)
• Next-GenAuto (EID & Dow)

Launch of
DuPont de
Nemours, Inc.	2021	2022	2023	2024

DuPont de Nemours, Inc.

2017

E.I. du Pont de Nemours	EID spin-off of
and Company (EID)1

2019

M&M Divestiture

EIDP1 now a subsidiary of

Corteva Agriscience

Phases

2017-19

• Execute complex merger / spin-offs
• Establish our vision & strategic direction
• Integrate & focus core businesses
• Define cultural principles & management approach

2020-23

• Complete portfolio re-shaping
• Focus on operational execution
• Manage through the pandemic, inflation, supply chain crisis & later inventory destocking challenges

2024 and Beyond

• Emphasis on delivering organic growth
• Next level Operational Excellence
• Deliver shareholder value
• Sustainability across the Enterprise
• Develop our People

Note: Direction of dotted arrows in chart above indicates whether a company was acquired or divested.	5
1 Effective January 1, 2023, Corteva's subsidiary, E.I. du Pont de Nemours and Company (EID) changed its name to EIDP, Inc. (EIDP).

Focused Multi-Year Transformation Strategy

PORTFOLIO OPTIMIZATION

OPERATIONAL EXCELLENCE

Separations/ Divestitures

• Separated Nutrition & Biosciences in 2021
• Divestiture of >$2B of other Non-CoreAssets
• Divestiture of majority of former Mobility & Materials segment to Celanese; ~$11B gross cash received

• Decentralized, market focused structure
• Accountability for manufacturing, operations and R&D in the business
• Best-in-classcost structure by reducing
  G&A costs
• Implementing Lean Enterprise program; continue to drive efficiencies

Performance- Based Design

Acquisitions

• Extended leadership positions in E&I segment through Laird Performance Materials acquisition in 2021 and Spectrum acquisition in 2023 which increased exposure to high- growth healthcare markets
• Opportunistic bolt-on M&A with focus on our key growth areas

• Balance sheet optimization; target ~2.0x
net debt/operating EBITDA	Efficient
• Strong investment grade credit rating
Capital
• Prudent capital allocation with focus on low
Structure
risk / high return organic expansions,
return of excess capital to shareholders

6

Balance Sheet Flexibility to Drive Value Creation

Total Debt (in Billions) as of March 31, 2024

Strong balance sheet

•	Committed to a strong investment grade credit profile
•	Targeting 2.0x adjusted net debt/EBITDA(1) leverage

$0.3

$0.5

• No significant long-term debt maturities until Nov 2025 ($1.85B)

Share repurchases

Total Adjusted

Debt1

~$8.6B

	$7.8
Long term debt	Net unfunded pension
Operating lease obligations

• Cash as of March 31, 2024: $1.9B

• Retired ~15% of common shares between Nov 2022 and April 2024
• Completed $500MM ASR in April 2024 under $1B share buyback program authorized in February 2024

Dividends(2)

• Declared 2Q'24 quarterly dividend of $0.38/share (annualized $1.52/share); 6% increase vs. 2023
• Targeting payout ratio of ~35-45%; grow dividend in line with earnings performance over time

Portfolio management and acquisitions

• Opportunistic bolt-on M&A with focus on our key growth areas

Internal investment

• CapEx ~5% of Net Sales in 2024; R&D ~4% of Net Sales
• Targeted at higher-growth businesses

Favorable balance sheet and liquidity position

(1)	Adjusted debt defined as gross debt with adjustments for pension and operating leases. EBITDA refers to operating EBITDA as defined on slide 47.	7
(2)	Future dividends subject to Board of Directors approval.

DuPont's Business Today

Focused on Five Growth Areas

Innovation-based growth aligned with key global macro themes

Electronics

29%

of net sales1

• Data centers / AI
• Consumer electronics
• Telecommunications

Enabling connectivity, smart technologies, and next- generation semiconductor chips and printed circuit boards

WaterProtectionIndustrial Technologies

12%		21%		28%
of net sales1		of net sales1		of net sales1
 Water filtration		Personal protection		Healthcare
		Construction		Aerospace
				General industrial
Addressing water scarcity	Protecting workers and	Specialized materials for
with solutions for clean	enabling sustainable	demanding environments
water and sustainable	buildings	including healthcare,
use			aerospace, packaging and
			clean energy

Quality portfolio with long-term growth potential

Next Generation

Automotive

10%

of net sales1

• Electric/hybrid vehicles
• Other advanced mobility

Transforming mobility by advancing electric vehicles and advanced safety systems

(1) Reflects estimated end-market exposure based on 2023 net sales on a continuing operations basis.

9

DuPont's Global Reach

2023 net sales by geography*

$12.1B

2023 Net Sales*

~24,000	35%	18%
Colleagues	HQ: Wilmington,	43%
	DE, USA

~100

Manufacturing Sites

~254%

Global Technical Centers

* Net sales and all other metrics on a continuing operations basis. Net sales reflects FY'23 and other metrics as of year-end 2023.

10